Published in Mol Cell Oncol on December 23, 2014
Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function. Oncotarget (2016) 0.75
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors. Cell Metab (2017) 0.75
Lipid (per) oxidation in mitochondria: an emerging target in the ageing process? Biogerontology (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
On the origin of cancer cells. Science (1956) 49.55
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature (2006) 11.76
Autophagy: renovation of cells and tissues. Cell (2011) 11.59
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18
TOR, a central controller of cell growth. Cell (2000) 10.41
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16
p53 regulates mitochondrial respiration. Science (2006) 9.06
The role of autophagy in cancer development and response to therapy. Nat Rev Cancer (2005) 8.18
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol (2010) 7.11
A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell (2006) 6.96
Autophagy mediates the mitotic senescence transition. Genes Dev (2009) 6.80
Ribonucleotide reductases. Annu Rev Biochem (2006) 6.35
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26
Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature (2010) 6.26
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem (1988) 4.79
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38
DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene (2007) 3.67
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46
Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem (2006) 3.45
Lipid metabolism in cancer. FEBS J (2012) 3.42
Oncogene-induced cell senescence--halting on the road to cancer. N Engl J Med (2006) 3.39
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene (2005) 2.77
Pro-senescence therapy for cancer treatment. Nat Rev Cancer (2011) 2.75
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol (2011) 2.69
Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem (2006) 2.68
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell (2011) 2.40
Cellular senescence and its effector programs. Genes Dev (2014) 2.37
Metabolic targets for cancer therapy. Nat Rev Drug Discov (2013) 2.32
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature (2013) 2.29
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev (2012) 2.06
Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev (2008) 2.05
The Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life (2010) 2.03
Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell (2012) 1.98
The RB-E2F1 pathway regulates autophagy. Cancer Res (2010) 1.90
Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell Host Microbe (2012) 1.82
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep (2013) 1.74
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature (2013) 1.66
Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol (2009) 1.61
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations. Cell Cycle (2012) 1.57
A metabolic prosurvival role for PML in breast cancer. J Clin Invest (2012) 1.57
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther (2012) 1.55
Oncogene-induced cellular senescence elicits an anti-Warburg effect. Proteomics (2013) 1.50
Oncogene-induced senescence pathways weave an intricate tapestry. Cell (2007) 1.47
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta (2012) 1.44
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene (2001) 1.36
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul (1999) 1.34
The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev (2012) 1.33
Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence. Am J Pathol (2012) 1.27
S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region. J Biol Chem (2003) 1.27
Targeting cancer metabolism--aiming at a tumour's sweet-spot. Drug Discov Today (2011) 1.21
p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res (2011) 1.20
De novo lipogenesis in health and disease. Metabolism (2014) 1.20
The control of nucleotide biosynthesis. Annu Rev Biochem (1968) 1.18
Autophagy facilitates oncogene-induced senescence. Autophagy (2009) 1.13
Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med (2013) 1.09
Tumor cell metabolism: an integral view. Cancer Biol Ther (2011) 1.04
Nuclear protein accumulation in cellular senescence and organismal aging revealed with a novel single-cell resolution fluorescence microscopy assay. Aging (Albany NY) (2011) 0.99
The multiple connections between pRB and cell metabolism. Curr Opin Cell Biol (2013) 0.95
Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett (2014) 0.94
Glycerophospholipid profile in oncogene-induced senescence. Biochim Biophys Acta (2011) 0.92
Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy (2013) 0.89
The oxidative phosphorylation system in mammalian mitochondria. Adv Exp Med Biol (2012) 0.89
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence. Cell Death Dis (2014) 0.84
Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. Cell Cycle (2013) 0.84
Pyruvate as a pivot point for oncogene-induced senescence. Cell (2013) 0.79
Metabolic changes during cellular senescence investigated by proton NMR-spectroscopy. Mech Ageing Dev (2013) 0.79
Viral subversion of autophagy impairs oncogene-induced senescence. Autophagy (2012) 0.77
Oncogenic H-Ras up-regulates acid β-hexosaminidase by a mechanism dependent on the autophagy regulator TFEB. PLoS One (2014) 0.76